217 related articles for article (PubMed ID: 10681733)
1. Fatal bone marrow aplasia during interferon-a treatment in chronic myelogenous leukemia.
Chiusolo P; Sica S; Laurenti L; Piccirillo N; Giordano G; Leone G
Haematologica; 2000 Feb; 85(2):212. PubMed ID: 10681733
[No Abstract] [Full Text] [Related]
2. Imatinib-related bone marrow aplasia after complete cytogenetic response in chronic myeloid leukemia.
Khan KA; Junaid A; Siddiqui NS; Mukhtar K; Siddiqui S
J Coll Physicians Surg Pak; 2008 Mar; 18(3):176-8. PubMed ID: 18460249
[TBL] [Abstract][Full Text] [Related]
3. [Myelofibrosis in patients with chronic myeloid leukemia treated with interferon-alpha].
Kumas Sotiris ; Semenova EA; Turkina AG; Zakharova AV; Domracheva EV; Khoroshko ND; Frank GA
Arkh Patol; 2003; 65(4):9-12. PubMed ID: 14518186
[TBL] [Abstract][Full Text] [Related]
4. Two siblings with chronic myelogenous leukemia.
Kapsali E; Tsiara S; Christou L; Panteli A; Bourantas KL
J Exp Clin Cancer Res; 2000 Dec; 19(4):541-3. PubMed ID: 11277336
[TBL] [Abstract][Full Text] [Related]
5. Rescue of interferon induced bone marrow aplasia in a patient with chronic myeloid leukemia by allogeneic bone marrow transplant.
Alabdulaaly A; Rifkind J; Solow H; Messner HA; Lipton JH
Leuk Lymphoma; 2004 Jan; 45(1):175-7. PubMed ID: 15061216
[TBL] [Abstract][Full Text] [Related]
6. Lymphoid blast crisis during interferon-alpha therapy in a patient with chronic myelogenous leukemia in myeloid blast crisis.
Goto H; Tsurumi H; Hara T; Moriwaki H
Int J Hematol; 2000 Dec; 72(4):474-6. PubMed ID: 11197215
[TBL] [Abstract][Full Text] [Related]
7. Chronic myeloid leukemia in accelerated phase with basophilic transformation of the bone marrow.
Cunningham MT; Ganguly S
Am J Hematol; 2006 May; 81(5):380-1. PubMed ID: 16628736
[No Abstract] [Full Text] [Related]
8. Systemic sarcoidosis associated with interferon-alpha treatment for chronic myelogenous leukemia.
Fiorani C; Sacchi S; Bonacorsi G; Cosenza M
Haematologica; 2000 Sep; 85(9):1006-7. PubMed ID: 10980653
[No Abstract] [Full Text] [Related]
9. Effects of chemotherapy (busulfan-hydroxyurea) and interferon-alfa on bone marrow morphologic features in chronic myelogenous leukemia. Histochemical and morphometric study on sequential trephine biopsy specimens with special emphasis on dynamic features.
Thiele J; Kvasnicka HM; Schmitt-Graeff A; Bundschuh S; Biermann T; Roessler G; Wasmus M; Diehl V; Zankovich R; Schaefer HE
Am J Clin Pathol; 2000 Jul; 114(1):57-65. PubMed ID: 10884800
[TBL] [Abstract][Full Text] [Related]
10. Recovery of normal hematopoiesis after severe bone marrow aplasia induced by interferon-alpha in a patient with chronic myelogenous leukemia.
Hishida A; Yamamoto K; Kato C; Yokozawa T; Emi N; Tanimoto M; Saito H
Int J Hematol; 2003 Jan; 77(1):55-9. PubMed ID: 12568300
[TBL] [Abstract][Full Text] [Related]
11. [Marked reduction of BCR-ABL fusion chromosome positive cells with interferon therapy combined with short-term imatinib in chronic myelogenous leukemia].
Ajima A; Takayama N; Hasegawa Y; Kojima H; Nagasawa T
Gan To Kagaku Ryoho; 2003 Nov; 30(12):1997-9. PubMed ID: 14650975
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of chronic myeloid leukemia with interferon-alpha].
Szomor A; Molnár L; Nagy A; Dávid M; Alizadeh H; Kecskés M; Vidra T; Kereskai L; Pajor L; Losonczy H
Orv Hetil; 2000 Nov; 141(48):2601-4. PubMed ID: 11141958
[TBL] [Abstract][Full Text] [Related]
13. Chronic myeloid leukemia following therapy with imatinib mesylate (Gleevec). Bone marrow histopathology and correlation with genetic status.
Frater JL; Tallman MS; Variakojis D; Druker BJ; Resta D; Riley MB; Hrisinko MA; Peterson LC
Am J Clin Pathol; 2003 Jun; 119(6):833-41. PubMed ID: 12817431
[TBL] [Abstract][Full Text] [Related]
14. Therapy-related changes of CD20+ and CD45RO+ lymphocyte subsets in chronic myeloid leukemia (CML): an immunohistochemical and morphometric study on sequential trephine biopsies of the bone marrow.
Thiele J; Kvasnicka HM; Schmitt-Graeff A; Cvetanovska G; Blum N; Schaefer HE
Mod Pathol; 2000 Aug; 13(8):888-96. PubMed ID: 10955456
[TBL] [Abstract][Full Text] [Related]
15. Gelatinous transformation of bone marrow in chronic myeloid leukemia during treatment with imatinib mesylate: a disease or a drug effect?
Ram R; Gafter-Gvili A; Okon E; Pazgal I; Shpilberg O; Raanani P
Acta Haematol; 2008; 119(2):104-7. PubMed ID: 18367829
[TBL] [Abstract][Full Text] [Related]
16. Role of interferon-alpha in chronic myeloid leukemia.
Kumar L; Basade M; Gulati SC
J Assoc Physicians India; 1995; Suppl 3():26-32. PubMed ID: 8773119
[No Abstract] [Full Text] [Related]
17. Regulation of the cytokine network by interferon: a potential mechanism of interferon in chronic myelogenous leukemia.
Peschel C; Aman MJ; Rudolf G; Aulitzky WE; Huber C
Semin Hematol; 1993 Jul; 30(3 Suppl 3):28-31. PubMed ID: 8235702
[No Abstract] [Full Text] [Related]
18. Acquired factor VIII inhibitor as presentation of chronic myelogenous leukemia during interferon-alpha therapy.
Zheng WL; Zhang GS; Shen JK; Pei MF; Peng HL; Xu M
Thromb Res; 2011 Aug; 128(2):202-3. PubMed ID: 21621826
[No Abstract] [Full Text] [Related]
19. Interferon-alpha-treated patients with chronic myelogenous leukemia show BCR/ABL-positive peripheral blood progenitor cells surviving long-term culture.
Schultheis B; Heissig B; Pasternak G; Hörner S; Hehlmann R
Folia Biol (Praha); 2000; 46(6):251-5. PubMed ID: 11140858
[TBL] [Abstract][Full Text] [Related]
20. Interferon therapy in chronic myelogenous leukemia.
Guilhot F; Roy L; Guilhot J; Millot F
Hematol Oncol Clin North Am; 2004 Jun; 18(3):585-603, viii. PubMed ID: 15271394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
